Australia markets open in 7 hours 38 minutes

Catalent, Inc. (CTLT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
54.000.00 (0.00%)
As of 12:22PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close54.00
Open54.07
Bid53.98 x 1000
Ask53.99 x 800
Day's range53.80 - 54.57
52-week range31.80 - 60.20
Volume297,169
Avg. volume1,773,096
Market cap9.773B
Beta (5Y monthly)1.18
PE ratio (TTM)N/A
EPS (TTM)-6.48
Earnings date27 Aug 2024 - 02 Sept 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est56.70
  • Business Wire

    Catalent Stockholders Approve Transaction with Novo Holdings

    SOMERSET, N.J., May 29, 2024--Catalent, Inc. ("Catalent," NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, today announced that, at its Special Meeting of Stockholders (the "Special Meeting") held earlier today, its stockholders voted to approve the pending transaction under which Novo Holdings A/S ("Novo Holdings") will acquire all outstanding shares of Catalent for $63.50 per share in cash (the "Merger").

  • Zacks

    Catalent's (CTLT) Latest Partnership to Boost Clinical Trials

    Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.

  • Zacks

    Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up

    Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.